Rebuilding Trust in Public Health and Public Health Law
As we rebuild trust in public health, we can begin to work toward reinstatement of public health law’s essential tools.
vaccines
-
Read more: Rebuilding Trust in Public Health and Public Health Law -
Read more: Failures of Imagination in Public Health Policy Failures of Imagination in Public Health Policy
If public health is to prosper, we will need to overcome the after-effects of several failures of imagination.
-
Read more: The End of Public Health? An Introduction to the Symposium The End of Public Health? An Introduction to the Symposium
Certain aspects of public health law as we know it are dead. In this symposium, we propose a path forward to create a “new public health” from the ashes.
-
Read more: The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA
The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million.
-
Read more: Using Legal Preparedness to Minimize Liability Barriers to Accessing Pandemic Vaccine and Medical Countermeasures Using Legal Preparedness to Minimize Liability Barriers to Accessing Pandemic Vaccine and Medical Countermeasures
Inefficiencies in negotiating vaccine procurement agreements during COVID-19 could have been attenuated with greater legal preparedness.
-
Read more: FRAND Terms for Pandemic-essential Intellectual Property Rights FRAND Terms for Pandemic-essential Intellectual Property Rights
The use of fair, reasonable and non-discriminatory (“FRAND”) terms in the licensing of intellectual property rights could foster cooperation in pandemics.
-
Read more: Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines? Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines?
Because of differences in how they were tested in clinical trials, it is difficult to make apples-to-apples comparisons for COVID-19 vaccines.
-
Read more: “Stick to the Science”? FDA, Ethics, and Pandemics “Stick to the Science”? FDA, Ethics, and Pandemics
This post reflects on the ethical implications of FDA’s use of its emergency powers, and suggests opportunities for greater accountability moving forward.
-
Read more: What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)? What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)?
A Biologics License Application, or BLA, is FDA’s standard “full approval” mechanism for biological products, including therapeutics and vaccines.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of April 2021.
